Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma

Patrizia Gasparini, Michela Casanova, R. Villa, Paola Collini, Rita Alaggio, Angelica Zin, P. Bonvini, Cristina R. Antonescu, Renata Boldrini, Roberto Caserini, Massimo Moro, Giovanni Centonze, Cristina Meazza, Maura Massimino, Luca Bergamaschi, Roberto Luksch, Stefano Chiaravalli, Gianni Bisogno, Nadia Zaffaroni, Maria Grazia Daidone & 2 others Gabriella Sozzi, Andrea Ferrari

Research output: Contribution to journalArticle

Abstract

Rhabdomyosarcoma (RMS) is the most frequent soft tissue tumor in childhood and arises from immature mesenchymal cells committed to skeletal muscle differentiation. Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in several cancers. Moreover, ALK full-length receptor protein has been observed in RMS, although its clinical and functional significance is yet controversial. The role of ALK and its clinical relevance were investigated in a selected cohort of 74 FFPE pediatric RMS and a panel of RMS cell lines, evaluating its gene and protein status, utilizing Fluorescent In Situ Hybridization (FISH), immunohistochemistry (IHC) and Western blot approaches. Moreover, to get insight into its possible therapeutic relevance, effects of ALK silencing on cell proliferation, invasion and apoptosis were studied in RMS cells. ALK IHC positivity was significantly correlated with gene copy number gain, the alveolar subtype, PAX3/7-FOXO1 rearrangements, the presence of metastasis at diagnosis and a worse overall outcome. Furthermore, EML4-ALK fusion gene associated with higher protein expression was identified in an embryonal RMS. ALK silencing in RH30 ALK positive cells strongly inhibited invasion capability. Overall, our data suggest a potential role of ALK in pediatric RMS.

Original languageEnglish
Pages (from-to)58903-58914
Number of pages12
JournalOncotarget
Volume7
Issue number37
DOIs
Publication statusPublished - 2016

Fingerprint

Rhabdomyosarcoma
Pediatrics
Immunohistochemistry
Embryonal Rhabdomyosarcoma
anaplastic lymphoma kinase
Proteins
Gene Dosage
Gene Fusion
Receptor Protein-Tyrosine Kinases
Therapeutic Uses
Fluorescence In Situ Hybridization
Neoplasms
Skeletal Muscle
Western Blotting
Cell Proliferation
Apoptosis
Neoplasm Metastasis
Cell Line

Keywords

  • Anaplastic lymphoma kinase
  • Chromosomal rearrangement
  • EML4-ALK
  • Metastasis
  • Rhabdomyosarcoma

ASJC Scopus subject areas

  • Oncology

Cite this

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma. / Gasparini, Patrizia; Casanova, Michela; Villa, R.; Collini, Paola; Alaggio, Rita; Zin, Angelica; Bonvini, P.; Antonescu, Cristina R.; Boldrini, Renata; Caserini, Roberto; Moro, Massimo; Centonze, Giovanni; Meazza, Cristina; Massimino, Maura; Bergamaschi, Luca; Luksch, Roberto; Chiaravalli, Stefano; Bisogno, Gianni; Zaffaroni, Nadia; Daidone, Maria Grazia; Sozzi, Gabriella; Ferrari, Andrea.

In: Oncotarget, Vol. 7, No. 37, 2016, p. 58903-58914.

Research output: Contribution to journalArticle

Gasparini, Patrizia ; Casanova, Michela ; Villa, R. ; Collini, Paola ; Alaggio, Rita ; Zin, Angelica ; Bonvini, P. ; Antonescu, Cristina R. ; Boldrini, Renata ; Caserini, Roberto ; Moro, Massimo ; Centonze, Giovanni ; Meazza, Cristina ; Massimino, Maura ; Bergamaschi, Luca ; Luksch, Roberto ; Chiaravalli, Stefano ; Bisogno, Gianni ; Zaffaroni, Nadia ; Daidone, Maria Grazia ; Sozzi, Gabriella ; Ferrari, Andrea. / Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma. In: Oncotarget. 2016 ; Vol. 7, No. 37. pp. 58903-58914.
@article{794c182ae5df4432b407f292ed562077,
title = "Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma",
abstract = "Rhabdomyosarcoma (RMS) is the most frequent soft tissue tumor in childhood and arises from immature mesenchymal cells committed to skeletal muscle differentiation. Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in several cancers. Moreover, ALK full-length receptor protein has been observed in RMS, although its clinical and functional significance is yet controversial. The role of ALK and its clinical relevance were investigated in a selected cohort of 74 FFPE pediatric RMS and a panel of RMS cell lines, evaluating its gene and protein status, utilizing Fluorescent In Situ Hybridization (FISH), immunohistochemistry (IHC) and Western blot approaches. Moreover, to get insight into its possible therapeutic relevance, effects of ALK silencing on cell proliferation, invasion and apoptosis were studied in RMS cells. ALK IHC positivity was significantly correlated with gene copy number gain, the alveolar subtype, PAX3/7-FOXO1 rearrangements, the presence of metastasis at diagnosis and a worse overall outcome. Furthermore, EML4-ALK fusion gene associated with higher protein expression was identified in an embryonal RMS. ALK silencing in RH30 ALK positive cells strongly inhibited invasion capability. Overall, our data suggest a potential role of ALK in pediatric RMS.",
keywords = "Anaplastic lymphoma kinase, Chromosomal rearrangement, EML4-ALK, Metastasis, Rhabdomyosarcoma",
author = "Patrizia Gasparini and Michela Casanova and R. Villa and Paola Collini and Rita Alaggio and Angelica Zin and P. Bonvini and Antonescu, {Cristina R.} and Renata Boldrini and Roberto Caserini and Massimo Moro and Giovanni Centonze and Cristina Meazza and Maura Massimino and Luca Bergamaschi and Roberto Luksch and Stefano Chiaravalli and Gianni Bisogno and Nadia Zaffaroni and Daidone, {Maria Grazia} and Gabriella Sozzi and Andrea Ferrari",
year = "2016",
doi = "10.18632/oncotarget.10368",
language = "English",
volume = "7",
pages = "58903--58914",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "37",

}

TY - JOUR

T1 - Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma

AU - Gasparini, Patrizia

AU - Casanova, Michela

AU - Villa, R.

AU - Collini, Paola

AU - Alaggio, Rita

AU - Zin, Angelica

AU - Bonvini, P.

AU - Antonescu, Cristina R.

AU - Boldrini, Renata

AU - Caserini, Roberto

AU - Moro, Massimo

AU - Centonze, Giovanni

AU - Meazza, Cristina

AU - Massimino, Maura

AU - Bergamaschi, Luca

AU - Luksch, Roberto

AU - Chiaravalli, Stefano

AU - Bisogno, Gianni

AU - Zaffaroni, Nadia

AU - Daidone, Maria Grazia

AU - Sozzi, Gabriella

AU - Ferrari, Andrea

PY - 2016

Y1 - 2016

N2 - Rhabdomyosarcoma (RMS) is the most frequent soft tissue tumor in childhood and arises from immature mesenchymal cells committed to skeletal muscle differentiation. Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in several cancers. Moreover, ALK full-length receptor protein has been observed in RMS, although its clinical and functional significance is yet controversial. The role of ALK and its clinical relevance were investigated in a selected cohort of 74 FFPE pediatric RMS and a panel of RMS cell lines, evaluating its gene and protein status, utilizing Fluorescent In Situ Hybridization (FISH), immunohistochemistry (IHC) and Western blot approaches. Moreover, to get insight into its possible therapeutic relevance, effects of ALK silencing on cell proliferation, invasion and apoptosis were studied in RMS cells. ALK IHC positivity was significantly correlated with gene copy number gain, the alveolar subtype, PAX3/7-FOXO1 rearrangements, the presence of metastasis at diagnosis and a worse overall outcome. Furthermore, EML4-ALK fusion gene associated with higher protein expression was identified in an embryonal RMS. ALK silencing in RH30 ALK positive cells strongly inhibited invasion capability. Overall, our data suggest a potential role of ALK in pediatric RMS.

AB - Rhabdomyosarcoma (RMS) is the most frequent soft tissue tumor in childhood and arises from immature mesenchymal cells committed to skeletal muscle differentiation. Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in several cancers. Moreover, ALK full-length receptor protein has been observed in RMS, although its clinical and functional significance is yet controversial. The role of ALK and its clinical relevance were investigated in a selected cohort of 74 FFPE pediatric RMS and a panel of RMS cell lines, evaluating its gene and protein status, utilizing Fluorescent In Situ Hybridization (FISH), immunohistochemistry (IHC) and Western blot approaches. Moreover, to get insight into its possible therapeutic relevance, effects of ALK silencing on cell proliferation, invasion and apoptosis were studied in RMS cells. ALK IHC positivity was significantly correlated with gene copy number gain, the alveolar subtype, PAX3/7-FOXO1 rearrangements, the presence of metastasis at diagnosis and a worse overall outcome. Furthermore, EML4-ALK fusion gene associated with higher protein expression was identified in an embryonal RMS. ALK silencing in RH30 ALK positive cells strongly inhibited invasion capability. Overall, our data suggest a potential role of ALK in pediatric RMS.

KW - Anaplastic lymphoma kinase

KW - Chromosomal rearrangement

KW - EML4-ALK

KW - Metastasis

KW - Rhabdomyosarcoma

UR - http://www.scopus.com/inward/record.url?scp=84991392572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991392572&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.10368

DO - 10.18632/oncotarget.10368

M3 - Article

VL - 7

SP - 58903

EP - 58914

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 37

ER -